Mergers & Acquisitions

1,000+ M&A transactions for an aggregate value of $465+ billion since 2019

Why Cooley
  • 180+ member team in 17 major business and technology centers in the US, Europe and Asia
  • Broad industry platform with clients across many industries and sophisticated capabilities in all practice areas
  • Excel in deals in the tech, life sciences, medical device and healthcare, consumer, education, defense and media industries
  • Given our market position in the medtech and life sciences sectors, we have handled a large number of life sciences M&A transactions, both public and private, and understand unique structuring issues for life sciences companies, including milestone structures, contingent value rights and option structures
  • Primary corporate counsel to 240+ public companies, giving us an unmatched perspective on market deal points and ability to facilitate introductions between buyers and sellers
  • Represent all categories of participants in transactions, including buyers, sellers, major stockholders, venture capitalists, lenders, financial advisors, management/founders, special board committees, individual investors, private equity funds, hedge funds and others 
  • Adept at handling all manner of transactions, including domestic and cross-border mergers and acquisitions, strategic deals including joint ventures, acquisitions of IP assets, patent cross-licenses, complex divestitures and spin-offs, takeover defense and shareholder activism counseling, and multibillion-dollar public company mergers
  • Robust SPAC experience and thought leaders in the area with a repository of market insight and guidance for businesses interested in the IPO alternative @ SPACtivity 
  • Market-leading IP, privacy, technology licensing, life sciences collaborations and licensing, regulatory, government contracts, credit finance, private equity, antitrust, employment, compensation and tax practices to support transactions

Public Company Innovation Hub

Resources for forward-thinking board members and leaders of US-listed public companies

Visit hub

  • Chambers: Band 2 for USA - Nationwide Corporate/M&A (2022)

  • Mergermarket: Top 3 for US M&A by Deal Count (2022 H1) 

  • Bloomberg: Top 4 for Global M&A by Deal Count (2022 H1)

  • Mergermarket: Top 4 for US M&A Exits by Deal Count (2021)

  • Mergermarket: Top 5 for Global M&A Exits by Deal Count (2021)

  • Bloomberg: #2 for US Mid-market M&A (2021)

  • Bloomberg: Top 3 for US Mid-market M&A by count (2021)

  • Bloomberg: #2 for Global Private Equity (2021)

  • Bloomberg: Top 3 for Global Private Equity by count (2021)

  • The Deal: Top 10 M&A Law Firms Power Rankings by count (2021)

  • Pitchbook: #5 Most Active Firm Globally Representing Companies (2021)

  • Pitchbook: #3 Most Active Firm in the US Representing Companies (2021)


M&A Blog

Newsworthy developments in the global mergers and acquisitions space

View blog

Group contacts
Barbara Borden  Partner San Diego
Jamie Leigh  Partner San Francisco
Steve Tonsfeldt  Partner Palo Alto
Garth Angelo Osterman  Partner San Francisco
Rama Padmanabhan  Partner San Diego
Kevin Mills  Senior Counsel Washington, DC
Ian A. Nussbaum  Partner New York
Alfred Browne  Partner Boston
Laura M. Medina  Partner Colorado
Justin Stock  Managing Partner – London London
David Bresnick  Partner London
Michal Berkner  Partner London
Stephen Rosen  Partner London
Christina Zhang  Partner in Charge – Shanghai Shanghai
Joshua Holleman  Partner Washington, DC
Miguel J. Vega  Partner Boston
Ben Beerle  Partner San Francisco
Aaron Binstock  Partner Washington, DC
Erin J. Kirchner  Partner Chicago
Kevin Cooper  Partner New York
Neal I. Aizenstein  Partner Chicago
Anne Lieberman  Partner Los Angeles – Santa Monica, Los Angeles – Downtown
David Silverman  Partner New York
Ben Shribman  Partner London
Nick Davis  Partner Seattle
Bill Sorabella  Partner New York
ViewHide related contacts


Listing Returned 0 Results.

ViewHide related news


Listing Returned 0 Results.

ViewHide related events


Listing Returned 0 Results.